(4-(benzo[b]thiophen-3-yl)-3-methoxyphenyl)((1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl)methanone

ID: ALA1083703

PubChem CID: 46890707

Max Phase: Preclinical

Molecular Formula: C26H29NO2S

Molecular Weight: 419.59

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)N2C[C@]3(C)C[C@H]2CC(C)(C)C3)ccc1-c1csc2ccccc12

Standard InChI:  InChI=1S/C26H29NO2S/c1-25(2)12-18-13-26(3,15-25)16-27(18)24(28)17-9-10-19(22(11-17)29-4)21-14-30-23-8-6-5-7-20(21)23/h5-11,14,18H,12-13,15-16H2,1-4H3/t18-,26-/m1/s1

Standard InChI Key:  UXYNEKLEPXVKQZ-WXTAPIANSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -3.2803   -1.9501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2814   -2.7843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5605   -3.2008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5623   -1.5337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0473   -1.6902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8409   -1.9463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8413   -2.7807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0470   -3.0376    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5586   -2.3611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9746    2.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7172    2.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4565    2.3943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7803    1.6124    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6364    1.5966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2855    0.9611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1139    0.9582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7921   -0.9056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0106   -0.7386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2668    0.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2822    0.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0909    0.4837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3432   -0.2982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0267    1.4415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6101    2.0248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6512    3.2008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2814    2.3943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6823    2.0100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    0.2094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3395    2.9456    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1496   -0.4720    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7329    0.1114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  4  2  0
 14 16  1  0
 15 16  1  0
  5  6  1  0
  7  8  1  0
 17 18  2  0
  8  9  1  0
 18 19  1  0
  9  5  2  0
 19 20  2  0
  4  1  1  0
 20 21  1  0
  6  7  1  0
 21 22  2  0
 22 17  1  0
 10 11  1  0
 20 23  1  0
 23 24  2  0
 23 13  1  0
 11 12  1  0
 12 25  1  0
  2  3  1  0
 12 26  1  0
 10 13  1  0
 10 27  1  0
 27 16  1  0
  3  7  2  0
 16 28  1  1
 12 14  1  0
 10 29  1  1
  1  2  2  0
 22 30  1  0
 13 15  1  0
 30 31  1  0
 17  5  1  0
M  END

Associated Targets(Human)

AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.59Molecular Weight (Monoisotopic): 419.1919AlogP: 6.62#Rotatable Bonds: 3
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.85CX LogD: 5.85
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.48Np Likeness Score: -0.81

References

1. Crombie AL, Antrilli TM, Campbell BA, Crandall DL, Failli AA, He Y, Kern JC, Moore WJ, Nogle LM, Trybulski EJ..  (2010)  Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.,  20  (12): [PMID:20471258] [10.1016/j.bmcl.2010.04.068]

Source